DashboardPortfoliosFavoritenGemeinschaftEntdeckenSuchen
NOT FOR DISTRIBUTION

Centrica plc

LSE:CNA Lagerbericht

Marktkapitalisierung: UK£6.8b

  • Unternehmensüberblick
  • Bewertung
  • Ausblick und Wachstum
  • Leistungs-Rückblick
  • Finanzlage
  • Dividende
  • Management
  • Eigentümerschaft
  • Weitere Informationen
  • Aktien-Community

Centrica Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Centrica wird ein jährliches Gewinn- und Umsatzwachstum von 4.9% bzw. 1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 4.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.2% betragen.

Wichtige Informationen

4.9%

Wachstumsrate der Gewinne

4.11%

EPS-Wachstumsrate

Integrated Utilities Gewinnwachstum7.8%
Wachstumsrate der Einnahmen1.0%
Zukünftige Eigenkapitalrendite17.16%
Analystenabdeckung

Good

Zuletzt aktualisiert02 Sep 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

User avatar
Narrative-Update • Aug 08

CNA: Recent Upgrades And Dividend Progress Will Support Future Upside

Centrica's updated analyst price target edges lower, with fair value now implied at £2.07 per share from £2.17, as analysts factor in a slightly higher discount rate, modestly lower profit margins and updated expectations for revenue growth and future P/E. Analyst Commentary Recent broker moves give a mixed but generally constructive picture around Centrica, with several firms revisiting ratings and price targets in light of the share price pullback and updated earnings assumptions.
Analyseartikel • Aug 03

Centrica's (LON:CNA) Earnings Offer More Than Meets The Eye

Centrica plc's ( LON:CNA ) stock didn't jump after it announced some healthy earnings. Our analysis showed that there...
User avatar
Narrative-Update • Jul 24

CNA: Higher Margins And Governance Reforms Will Support Future Upside

Centrica's analyst price target has been trimmed slightly, with recent cuts of £4 to £214 at Citi and £8 to £227 and then £10 to £235 at JPMorgan, reflecting adjustments to revenue expectations alongside modest tweaks to fair value and forward P/E assumptions, while profit margin estimates have edged higher. Analyst Commentary Recent research on Centrica shows a mix of optimism and caution, with price targets clustered in a relatively tight range and most firms maintaining positive ratings even as they fine tune their assumptions.
User avatar
Narrative-Update • Jun 24

CNA: Low Carbon Partnerships And Governance Updates Will Support Future Upside

Analysts have adjusted their price targets for Centrica, with a new blended target moving modestly and anchored around recent changes that include Berenberg lifting its target to £2.30 and JPMorgan trimming its target to £2.35. These revisions reflect updated views on fair value, discount rate and assumptions for revenue growth, profit margin and future P/E.
User avatar
Narrative-Update • Jun 08

CNA: Low Carbon And On Site Power Partnerships Will Support Future Upside

Analysts have nudged the blended price target for Centrica higher into the low £2 range, reflecting adjusted revenue growth, profit margin and future P/E assumptions, along with recent target moves between £1.90 and £2.35 from several major banks. Analyst Commentary Recent Street research on Centrica shows price targets generally clustering between £2.00 and £2.35, with several changes to both ratings and target levels over the past few months.
User avatar
Narrative-Update • May 24

CNA: Low Carbon And On Site Power Projects Will Shape Balanced Outlook

Analysts have lifted their blended price target for Centrica, with recent moves such as Berenberg's shift to £2.30 from £1.90, several JPMorgan adjustments around the £2.24 to £2.35 range, and higher targets from Goldman Sachs and RBC, reflecting updated views on revenue growth, profit margins and valuation multiples. Analyst Commentary Recent research on Centrica shows a split view, with several price target increases and a cluster of rating downgrades that revolve around execution risk, valuation and the timing of potential earnings growth.
User avatar
Narrative-Update • Apr 27

CNA: Low Carbon Projects And On Site Power Will Shape Balanced Outlook

The analyst price target for Centrica has been raised, with recent Street research pointing to a cluster of higher targets in the £2.00 to £2.32 range, as analysts highlight the company’s positioning in low carbon generation and recent energy market disruption. Analyst Commentary Recent research shows a mix of optimism and caution around Centrica, with several firms adjusting ratings and price targets in a relatively tight range around £2.00 to £2.32.
User avatar
Narrative-Update • Apr 12

CNA: Low Carbon Projects And On Site Power Partnerships Will Support Fair Outlook

Centrica's analyst price target has edged higher to £2.19 from £2.16, as analysts point to recent price target increases across the Street and see support from disruption in energy markets and the company's positioning in low carbon generation. Analyst Commentary Recent Street research around Centrica shows a mix of optimism on the long term setup and caution on near term execution and valuation, which is reflected in both upgrades and downgrades alongside a cluster of higher price targets.
User avatar
Narrative-Update • Mar 28

CNA: Fair View Sees Low Carbon Projects Offsetting Limited Near Term Triggers

The analyst price target for Centrica has been revised higher to £2.16 per share. The change is supported by recent research pointing to adjusted revenue growth assumptions, a slightly different profit margin outlook, and a higher future P/E multiple as analysts respond to rising price targets and rating changes across several firms.
User avatar
Narrative-Update • Mar 13

CNA: Fair View Balances Low Carbon Upside With Fewer Near Term Catalysts

The analyst price target for Centrica has edged higher to reflect a modest uplift in fair value to £2.05 and a slightly richer future P/E assumption, as analysts balance higher UK low carbon and gas price tailwinds against recent share gains and fewer near term catalysts. Analyst Commentary Recent research on Centrica shows a split between bullish and bearish analysts, with several raising price targets while others have turned more cautious after the share price recovery and completion of the buyback.
User avatar
Narrative-Update • Feb 25

CNA: Neutral Stance Will Rely On Execution Against Tight P/E Expectations

Centrica's analyst fair value estimate has edged up to reflect higher price targets in the £2.24 to £2.32 range, with analysts citing adjusted expectations for revenue growth, improved profit margin assumptions, and a lower expected future P/E of 11.4x. Analyst Commentary Recent research has clustered Centrica's price targets in the £2.24 to £2.32 range, with several banks adjusting their numbers in quick succession.
User avatar
Narrative-Update • Feb 10

CNA: Neutral View Will Depend On Execution And Valuation Discipline

Analysts have nudged their fair value estimate for Centrica slightly higher to £1.98 from £1.96, citing updated assumptions around revenue growth, profit margins and a modestly higher future P/E, which are consistent with recent upward price target moves from several firms. Analyst Commentary Recent updates from bullish analysts have focused on higher price targets and slightly richer valuation assumptions that they see as better aligned with current market expectations for Centrica.
User avatar
Narrative-Update • Jan 24

CNA: Neutral Stance Will Hinge On Execution And Margin Resilience

Analysts have trimmed their fair value estimate for Centrica slightly, now seeing it closer to £1.96 per share. Updated assumptions on revenue growth, profit margins and future P/E have led to a more cautious stance, which is reflected in the recent move to a Neutral rating with a £1.85 price target.
User avatar
Narrative-Update • Jan 10

CNA: Energy Transition Execution Will Shape Balanced Future Risk Reward Profile

Analysts have slightly raised their fair value estimate for Centrica from £1.97 to £1.98 per share, reflecting a mix of more cautious and more constructive views after recent rating changes and updated price targets across the sector. Analyst Commentary Recent rating changes on Centrica show a mix of optimism and caution, which helps explain why the fair value move has been incremental rather than dramatic.
User avatar
Narrative-Update • Dec 26

CNA: Energy Transition Execution Will Drive Long Term Earnings Momentum

Analysts have nudged their fair value estimate for Centrica slightly higher to approximately £1.97 from about £1.96. They cite a broadly stable discount rate, marginally stronger revenue growth expectations and modestly higher sector upside that is partly tempered by a more balanced risk reward profile.
User avatar
Narrative-Update • Dec 11

CNA: Cost Cutting Plan Will Support Long Term Earnings Momentum

Analysts have nudged their average price target for Centrica slightly lower to about £1.96. This reflects a modest recalibration of fair value assumptions, even as they highlight potential upside from sector tailwinds, improving renewables exposure, and prospective cost cutting initiatives.
User avatar
Narrative-Update • Nov 27

CNA: Cost Cutting Plan And Renewables Outlook Will Support Long Term Gains

Centrica's analyst price target has been raised slightly to £2.10. Analysts cite further upside potential in European utilities and an improving outlook for renewables as supporting factors.
Analyseartikel • Nov 24

Centrica (LON:CNA) Has A Somewhat Strained Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
Narrative-Update • Nov 13

CNA: Renewables Momentum and Nuclear Developments Will Drive Further Upside Potential

The analyst price target for Centrica has been increased, now ranging from 179 GBp to 210 GBp. Analysts cite expectations of continued earnings momentum, further upside potential in UK utilities, and an improved outlook for renewables. Analyst Commentary Recent analyst research on Centrica highlights both optimistic perspectives and ongoing areas of caution regarding the company's growth trajectory and valuation outlook.
User avatar
Narrative-Update • Oct 29

Nuclear Agreements And Renewables Momentum Will Shape Energy Outlook

Analysts have revised their price targets for Centrica higher. New targets have risen from £1.77 to a range as high as £2.10, citing ongoing momentum in UK utilities, an improved outlook for renewables, and potential for future earnings growth.
Analyseartikel • Oct 28

An Intrinsic Calculation For Centrica plc (LON:CNA) Suggests It's 21% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Centrica fair value estimate is UK£2.24 Centrica is estimated...
User avatar
Narrative-Update • Oct 15

Sizewell C And Morecambe Net Zero Will Drive Energy Transformation

Centrica's analyst price target has increased from 180 GBp to 210 GBp, as analysts see upside potential driven by improving renewables prospects and cost-cutting initiatives within the UK utility sector. Analyst Commentary Recent analyst research on Centrica highlights optimism around the company's future prospects, as well as some areas where caution may be warranted.
User avatar
Narrative-Update • Sep 28

Sizewell C And Morecambe Net Zero Will Drive Energy Transformation

Analysts have raised Centrica’s price target slightly to £1.93, citing its strong positioning among UK utilities, improved earnings momentum, and anticipated cost-cutting efforts, while overall fair value remains nearly unchanged. Analyst Commentary Bullish analysts highlight Centrica as a top pick in UK utilities due to its strong relative positioning.
User avatar
Narrative-Update • Sep 13

Sizewell C And Morecambe Net Zero Will Drive Energy Transformation

Cautious optimism among analysts, grounded in Centrica’s strong past sector outperformance and a balanced risk/reward outlook, has led to a marginal increase in the consensus price target from £1.87 to £1.90. Analyst Commentary Bullish analysts see modest upside potential, reflected in minor price target increases.
User avatar
Neues Narrative • Feb 23

Investments In Flexible Generation And Technology Will Streamline Operations, But Revenue Decline And Margin Pressures Are Anticipated

Increased customer engagement and service delivery in Services and Solutions could drive revenue growth and improve net margins.

Gewinn- und Umsatzwachstumsprognosen

LSE:CNA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202821,30271225988310
12/31/202721,50860111460610
12/31/202621,210537-33543010
6/30/202619,549711-172428N/A
3/31/202619,521320-15562N/A
12/31/202519,492-72141695N/A
9/30/202519,494-158153670N/A
6/30/202519,496-244164645N/A
3/31/202519,705544449897N/A
12/31/202419,9131,3327331,149N/A
9/30/202420,1991,2187371,107N/A
6/30/202420,4841,1047411,065N/A
3/31/202423,4712,5171,5791,909N/A
12/31/202326,4583,9292,4172,752N/A
9/30/202328,2004,0812,8643,193N/A
6/30/202329,9414,2323,3103,634N/A
3/31/202326,8411,7252,1272,474N/A
12/31/202223,741-7829431,314N/A
9/30/202220,941-9018461,266N/A
6/30/202218,141-1,0217491,218N/A
3/31/202216,443-2179701,415N/A
12/31/202114,7445861,1911,611N/A
9/30/202113,7907009341,333N/A
6/30/202112,8358146771,055N/A
3/31/202112,5422707941,228N/A
12/31/202012,249-2749111,400N/A
6/30/20207,758-7591,2861,976N/A
3/31/202010,376-861N/A1,613N/A
12/31/201912,994-964N/A1,250N/A
9/30/201922,724-814N/A1,243N/A
6/30/201922,773-605N/A1,235N/A
3/31/201923,039-211N/A1,585N/A
12/31/201823,304183N/A1,934N/A
9/30/201824,570354N/A1,771N/A
6/30/201825,835524N/A1,607N/A
3/31/201826,935426N/A1,724N/A
12/31/201728,035328N/A1,840N/A
9/30/201728,028447N/A1,989N/A
6/30/201728,021566N/A2,137N/A
3/31/201727,5621,119N/A2,267N/A
12/31/201627,1021,672N/A2,396N/A
9/30/201626,501512N/A2,311N/A
6/30/201625,900-649N/A2,225N/A
3/31/201626,936-698N/A2,211N/A
12/31/201527,971-747N/A2,197N/A
9/30/201528,541-621N/A1,850N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CNADas prognostizierte Gewinnwachstum (4.9% pro Jahr) liegt über der Sparquote (3.6%).

Ertrag vs. Markt: CNADie Erträge des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt UK (11.2% pro Jahr).

Hohe Wachstumserträge: CNADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CNADie Einnahmen des Unternehmens (1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt UK (3.7% pro Jahr).

Hohe Wachstumseinnahmen: CNADie Einnahmen des Unternehmens (1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CNADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17.2%).


Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/09/13 19:29
Aktienkurs zum Tagesende2026/09/11 00:00
Gewinne2026/06/30
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
  • SEC-Formular 10-K
  • SEC-Formular 10-Q
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
  • Analysten Research Berichte
  • Blue Matrix
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
  • ICE-Marktdaten
  • SEC-Formular S-1
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
  • SEC-Formular 4
  • SEC-Formular 13D
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
  • SEC-Formular 10-K
  • SEC-Formular DEF 14A
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens
  • SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.

Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Centrica plc wird von 24 Analysten beobachtet. 12 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Mark HivesBarclays
Dominic NashBarclays
Peter CramptonBarclays

Triff überall bessere Investmententscheidungen

Zum Herunterladen scannen
App Store öffnenGoogle Play öffnen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Datenquellen anzeigen
Märkte
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideen für Investitionen
  • Unterbewertete Unternehmen
  • Dividendenstarke Unternehmen
  • Insider-Käufe
  • Kernenergie
  • Autonome Fahrzeuge
  • Künstliche Intelligenz
  • Kryptowährung und Blockchain
  • Cybersicherheit
  • Weitere Ideen
Börsengemeinschaften
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Werkzeuge und Funktionen
  • Portfolio-Tracker
  • Aktien-Screener & Alarme
  • Erzählungen & faire Werte
  • Dividenden-Rechner
Nachrichten & Entdeckungen
  • Neueste Bestandsnachrichten
  • Globale Markteinsichten
  • Der Fuchsbau
  • Ideen für Investitionen
  • Community-Erzählungen
  • Was gibt's Neues?
Simply Wall St
  • Pläne & Preisgestaltung
  • Werbung},{
  • Über uns
  • Kontakt
  • Karriere
  • Hilfe-Center
  • Lernen Sie das Investieren in Aktien
  • Partnerprogramm
  • Business & Unternehmen
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Bedingungen und Konditionen
  • Datenschutzbestimmungen
  • KI-Bedingungen
  • Leitfaden für Finanzdienstleistungen